I'm in at $3 and will triple up at $2.80. Agree with some posters here about a possible return to the cap raise price. Why not wait and see what happens safely on the sidelines?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025